v3.25.2
Note 7 - Accounts Payable and Accrued Liabilities - Accounts Payable and Accrued Liabilities (Details) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current accounts payable $ 533,763 $ 484,934
Accrued liabilities 322,548 309,332
Deferred accounts payable 1,179,647 1,039,304
Deferred compensation to directors 1,723,048 1,891,120 [1]
Total accounts payable 1,713,410 1,524,238
Total accrued liabilities $ 2,045,596 $ 2,200,452
[1] The director fees and interest accrued under the deferred Compensation Plan where most directors elected to defer 100% of their fees for 2025, 2024, 2023, 2022, 2021 and 2020 excluding Jan Loeb who was nominated to the Board on July 28, 2023, and elected to a three-year term at the annual shareholder meeting on October 12, 2023. This amount also includes the deferred compensation of a former Board advisor per an agreement to defer payments due under an advisor agreement and two previous Board members.